BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22884399)

  • 61. Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
    Brahm CG; den Hollander MW; Enting RH; de Groot JC; Solouki AM; den Dunnen WFA; Heesters MAAM; Wagemakers M; Verheul HMW; de Vries EGE; Pruim J; Walenkamp AME
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2404-2412. PubMed ID: 30032322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
    Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
    Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
    Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
    Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
    Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
    J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
    Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
    J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
    Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
    Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy.
    Sijens PE; Heesters MA; Enting RH; van der Graaf WT; Potze JH; Irwan R; Meiners LC; Oudkerk M
    Cancer Invest; 2007 Dec; 25(8):706-10. PubMed ID: 18058466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics.
    Ma L; Song ZJ
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2489-95. PubMed ID: 24183513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences.
    Raab P; Hattingen E; Franz K; Zanella FE; Lanfermann H
    Radiology; 2010 Mar; 254(3):876-81. PubMed ID: 20089718
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
    Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
    J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla.
    Alvarez-Linera J; Benito-León J; Escribano J; Rey G
    J Neuroimaging; 2008 Jul; 18(3):276-81. PubMed ID: 18482368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.
    Belliveau JG; Bauman GS; Macdonald D; Macdonald M; Klassen LM; Menon RS
    J Med Imaging Radiat Oncol; 2018 Apr; 62(2):224-231. PubMed ID: 29193849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
    Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
    Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cerebral blood flow changes after radiation therapy identifies pseudoprogression in diffuse intrinsic pontine gliomas.
    Calmon R; Puget S; Varlet P; Dangouloff-Ros V; Blauwblomme T; Beccaria K; Grevent D; Sainte-Rose C; Castel D; Debily MA; Dufour C; Bolle S; Dhermain F; Saitovitch A; Zilbovicius M; Brunelle F; Grill J; Boddaert N
    Neuro Oncol; 2018 Jun; 20(7):994-1002. PubMed ID: 29244086
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diffusion-sensitized ophthalmic magnetic resonance imaging free of geometric distortion at 3.0 and 7.0 T: a feasibility study in healthy subjects and patients with intraocular masses.
    Paul K; Graessl A; Rieger J; Lysiak D; Huelnhagen T; Winter L; Heidemann R; Lindner T; Hadlich S; Zimpfer A; Pohlmann A; Endemann B; Krüger PC; Langner S; Stachs O; Niendorf T
    Invest Radiol; 2015 May; 50(5):309-21. PubMed ID: 25612144
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differentiation of Low- and High-Grade Pediatric Brain Tumors with High b-Value Diffusion-weighted MR Imaging and a Fractional Order Calculus Model.
    Sui Y; Wang H; Liu G; Damen FW; Wanamaker C; Li Y; Zhou XJ
    Radiology; 2015 Nov; 277(2):489-96. PubMed ID: 26035586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.